Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | breast cancer 1, early onset | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0015 | 0 | 0.5 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0054 | 0.1232 | 0.1232 |
Loa Loa (eye worm) | hypothetical protein | 0.0171 | 0.4963 | 0.4963 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0054 | 0.1232 | 0.1232 |
Schistosoma mansoni | tar DNA-binding protein | 0.0328 | 1 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0015 | 0 | 0.5 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0015 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0015 | 0 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0328 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0328 | 1 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0054 | 0.1232 | 0.1232 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.1232 | 0.1232 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0015 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 0.3236 | 0.3236 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0171 | 0.4963 | 0.4963 |
Schistosoma mansoni | tar DNA-binding protein | 0.0328 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.1232 | 0.1232 |
Echinococcus multilocularis | GPCR, family 2 | 0.0054 | 0.1232 | 0.1232 |
Schistosoma mansoni | hypothetical protein | 0.0117 | 0.3236 | 0.3236 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0054 | 0.1232 | 0.1232 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.1232 | 0.1232 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0054 | 0.1232 | 0.1232 |
Schistosoma mansoni | tar DNA-binding protein | 0.0328 | 1 | 1 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0015 | 0 | 0.5 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0054 | 0.1232 | 0.1232 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0015 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0328 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0171 | 0.4963 | 0.4963 |
Schistosoma mansoni | tar DNA-binding protein | 0.0328 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0117 | 0.3236 | 0.3236 |
Echinococcus multilocularis | tar DNA binding protein | 0.0328 | 1 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0328 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.1232 | 0.1232 |
Loa Loa (eye worm) | TAR-binding protein | 0.0328 | 1 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0054 | 0.1232 | 0.1232 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0054 | 0.1232 | 0.1232 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.1232 | 0.1232 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0328 | 1 | 1 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0015 | 0 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0328 | 1 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0015 | 0 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0171 | 0.4963 | 0.4963 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0015 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 8.9125 uM | PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.